JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients (Q42988733)
Jump to navigation
Jump to search
scientific article published on 24 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients |
scientific article published on 24 June 2013 |
Statements
1 reference
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients (English)
1 reference
Paul J Pockros
1 reference
Donald Jensen
1 reference
Naoky Tsai
1 reference
Ryan Taylor
1 reference
Alnoor Ramji
1 reference
Curtis Cooper
1 reference
Rolland Dickson
1 reference
Alan Tice
1 reference
Rohit Kulkarni
1 reference
John M Vierling
1 reference
Marie Lou Munson
1 reference
Ya-Chi Chen
1 reference
Isabel Najera
1 reference
James Thommes
1 reference
JUMP-C Investigators
1 reference
24 June 2013
1 reference
1 reference
58
1 reference
2
1 reference
514-523
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference